First Trust NYSE Arca Biotechnology Index Fund
236 hedge funds and large institutions have $921M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 83 reducing their positions, and 30 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
0% more funds holding
Funds holding: 236 → 236 (0)
0.36% less ownership
Funds ownership: 47.93% → 47.58% (-0.36%)
6% less capital invested
Capital invested by funds: $977M → $921M (-$55.9M)
27% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 83
50% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $2.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
+$6.24M |
| 2 |
HF
HRT Financial
New York
|
+$5.85M |
| 3 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$5.19M |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$4.77M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$4.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$12.3M |
| 2 |
Morgan Stanley
New York
|
-$11M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.69M |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$4.37M |
| 5 |
IMC Chicago
Chicago,
Illinois
|
-$4.04M |
FBT Hedge Fund Activity: Q1 2021 in Review
236 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2021, worth a combined $921M — down 5.7% from $977M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new FBT positions and 30 closed out — a net gain of 3 holders — while 61 added to existing stakes and 83 trimmed.
The largest buyer was Navellier & Associates, opening a new position worth an estimated $6.24M. The largest seller was LPL Financial, cutting an estimated $12.3M.
- 236 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $921M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2021, down 5.7% quarter-over-quarter.
- 33 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2021 and 30 closed out, a net change of +3 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2021 was Navellier & Associates, an estimated $6.24M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2021 was LPL Financial, an estimated $12.3M sold.
Based on aggregated 13F filings for Q1 2021.